Trial Profile
Phase 3 study of ABP-700
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Cyclopropyl-methoxycarbonylmetomidate (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 17 May 2016 New trial record
- 09 May 2016 According to the Medicines company, company plans to initiate this study in 2017.